In a previous study, ANRIL overexpression in human prostate tumour cells was shown to repress INK4b/INK4A mRNAs expression, and this repression was mediated through the direct binding of ANRIL to the PRC1 component, chromobox homologue 7 (CBX7). Here, CDKN2B-AS1 is linked to prostate neoplasm.